Fund Holdings — Qiming U.S. Ventures Management, LLC

Total Portfolio Value:
$23.62M
Total Bought:
$0
Total Sold:
$0
Net Transaction:
$0
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Tourmaline Bio Inc741,691741,6910$11.28M$11.86M50.22%+$578.5K
Jasper Therapeutics, Inc.(JSPR)928,964928,9640$3.99M$5.16M21.83%+$1.16M
Korro Bio, Inc.(KRRO)368,085368,0850$6.41M$4.60M19.47%-$1.81M
Ventyx Biosciences Inc412,225412,2250$474.1K$882.2K3.74%+$408.1K
Hillevax Inc372,615372,6150$540.3K$741.5K3.14%+$201.2K
Kezar Life Sciences Inc
COM NEW
82,87182,8710$404.4K$379.5K1.61%-$24.9K
Page 1 of 1
Qiming U.S. Ventures Management, LLC — 13F Holdings — Q2 2025 | TickerTrail